AzTrials
AzTrials

Cause of MortalitySEACTN-VANCT04595656

Defining Causes of Deaths in South and Southeast Asia

An observational study of Cause of Mortality and Cause of Neonatal Death, run by University of Oxford at 5 sites in 5 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Brief Summary: Mortality data are important in low and middle-income countries to assess the population health status and trends. Mortality statistics in the populations of Bangladesh, Myanmar and Lao PDR are considered as generally limited and a recent assessment of vital registration systems of those countries… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
verbal autopsy interview
How many people
3,413 participants
Where
5 sitesin 5 countries
Study dates
1 Sep 2021to 30 Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The respondent should be a close family member or a caregiver or a person who closely attended to the deceased during the illness (e.g. the mother in the case of an infant death, the spouse in case of an adult death, the son/daughter in the case of deaths among the elderly and an adult female relative in case of maternal deaths); and the respondent's educational status and communication skills. If needed, another household member or neighbor can help the primary respondents for specific details.

Who may be able to join

  • All adult participants whose family member's death occurred in SEACTN villages within 12 months.

Who cannot join

  • Participants whose family member's death occurred outside of SEACTN villages or deaths more than 12months
  • Respondents who are not providing informed consent

Trial locations and contacts

5 sites in 5 countries.

5 sites in 5 countries

Bangladesh1 site
  • Building Resources Across Communities (BRAC)

    Dhaka

Other trials in Bangladesh

Burma1 site
  • villages in Thai-Myanmar border

    Myawady, Kayin State

Other trials in Burma

Cambodia1 site
  • Action for Health Development (AHEAD)

    Battambang

Other trials in Cambodia

Laos1 site
  • Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)

    Vientiane

Other trials in Laos

Thailand1 site
  • Chiangrai Clinical Research Unit (CCRU)

    Chiang Rai

Other trials in Thailand

About this study

Official title: Defining Burden of Diseases and Causes of Deaths Using Electronic Verbal Autopsy Methods in Rural South and Southeast Asia: A Multi-centre Study in Bangladesh, Lao PDR, Thailand, Cambodia and Myanmar

Brief Summary: Mortality data are important in low and middle-income countries to assess the population health status and trends. Mortality statistics in the populations of Bangladesh, Myanmar and Lao PDR are considered as generally limited and a recent assessment of vital registration systems of those countries reported a poor performance of the death registration system. Majority of deaths occur at home in rural area of those countries without cause of death assigned. To address this problem, the investigators will use verbal autopsy (VA) method developed by WHO to ascertain the cause of a death based on an interview with a family member or caregiver of deceased person to obtain information about causes of death in study rural communities. Death related to a specific cause will be defined by ICD-10 codes and described as primary, secondary or underlying COD. The study is planned to conduct in approximately 390 rural village communities covered by Southeast Asia clinical trial network (SEACTN) network in proposed 3 countries. The study findings will help establish a better understanding in signs, symptoms, medical history and circumstances preceding death; prioritize future interventions for early and effective diagnostics and treatment for diseases and how to keep mortality surveillance ongoing in study rural settings.

This study is funded by Welcome Trust. Welcome Trust grant reference number is [215604/Z/19/Z].

Read the detailed description

The SEACTN (South and Southeast Asian Community-based Trials Network) is a part of a portfolio of programmes under the Wellcome Innovations Flagship 'Innovations for Impact in Resource-limited Settings'. The flagship plan is to build the SEACTN infrastructure in approximately 520 villages across three South and Southeast Asian countries (Bangladesh, Lao PDR, Thailand, Cambodia and Myanmar) to capture over 100,000 episodes and outcomes of rural febrile illness in these remote and underserved communities. Mortality statistics in the populations covered by SEACTN are considered as generally limited and unreliable and a recent assessment of vital registration systems of these 3 countries showed a poor performance of the death registration system. To support the goal of the flagship SEACTN program in defining the morbidity and mortality burden of febrile illness and to strengthen the mortality data (causes of deaths information) in study areas, the VA component is integrated as a part of project activities. It will identify not only potential causes of deaths with a history of febrile illnesses, but also all other CODs which occur in SEACTN network communities. The findings will also uncover large gaps and challenges that impede delivery of primary health services in rural area of the countries.

This observational multicountry study aims to conduct verbal autopsies in approximately 390 rural village communities in the SEACTN network in 5 countries; Bangladesh (in Cox's Bazar and Bandarban districts), Lao PDR (in Phalanxay, Phin and Atsaphanthong districts in the Province of Savannakhet), Thailand (Muang district of Chiang Rai province), Cambodia (Battambang and Pailin provinces)and Thai-Myanmar border area (Kayin state, Myanmar). The study populations are restricted to varying degrees from accessing adequate health services due to geographical and financial factors. Since VA interviews will be carried out for all deaths, the study will be able to point out capacity gaps in providing essential health services at different levels of the health system as well as barriers in receiving healthcare services. About 2,000 deaths or VA interviews are expected to be carried out over a 2-year study period.

Study procedure: The death cases in villages will be notified by village health workers (VHWs) or community health workers (CHWs) and also be checked through health facilities records. The study respondent should be a close family member or a caregiver or a person who closely attended to the deceased during the illness. VA instrument Questionnaires WHO 2016 version of validated electronic VA questionnaires will be used and there are three separate VA forms for specific age groups: perinatal and neonatal mortality (death of a child under 4 weeks), child mortality (aged 4 weeks to 11 years), adult mortality (aged 12 years and over) including maternal mortality. VA cause of death list The WHO VA cause of death list is used to classify disease. The COD list is based on the international classification of diseases (ICD-10) coding system.

The training of interviewers will be via online and face to face training sessions. The training materials from research collaborators (University of Toronto, Canada) will be used and adapted in local context. There will also be web based intensive courses for physicians for coding and CoD certification. A VA needs an optimum recall period for high quality of information. To keep the recall period as short as possible and to get reliable information, field team will aim to visit the villages at 3-6 months intervals and conduct interviews with the respondents of deceased persons to collect the information. The interview will take approximately 30 to 45 minutes to complete using electronic format of questionnaires installed in CommCare apps of SEACTN tablets after getting informed consent. Audio recordings will be done to make sure for accurate records of the interviews and to complete the narrative text section of the form. The investigators will also record the location of the villages by GPS in order to define causes of deaths with a map.

For quality control of the interview process, 10 percent of interviews will be observed and checked by field supervisors while conducting interviews. For quality control of coding and, assessing the COD, two physicians will independently review the outcome of an interview, will provide coding and formulate a COD. The COD identified by each physician will be recorded in the database and if there is any disagreement, a third senior physician would be brought in to adjudicate the result and sought for a solution.

Being tested
verbal autopsy interview
Keywords
Death, fatal outcome, interview, mortality, pathologic process
Medical subject headings
Death, Pathologic Processes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • verbal autopsy interviewOther

    The study involves filling of verbal autopsies for deaths in SEACTN villages. This is an observational study being conducted as a substudy of rural febrile project of SEACTN program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ~2,000 deaths classified according to ICD-10 classification

    Classification of causes of deaths by verbal autopsy methods in rural areas of South and Southeast Asia: Based on information from the VA interview, the study physicians will identify possible causes of death. Death related to a specific cause will be defined by ICD-10 codes and described as primary, secondary or underlying COD.

    Measured: 18-20 months recruitment

Secondary outcomes (5)
  1. Age standardized mortality rate, gender specific CODs

    Estimation of age standardized mortality rates and gender specific cause of deaths: we will use age/sex standardized mortality estimates for comparison of study population health among study sites.

    Measured: 18-20 months of recruitment period

  2. Spatiotemporal mortality by causes

    Mapping of causes of death by location, period and seasonal variations Our field operation teams will collect the VA data with GPS installed tablets device with the purpose of assessing the location of areas with a high or low concentration of deaths in a particular time period or season.

    Measured: 18-20 months of recruitment period

  3. Numbers of deaths with acute febrile illness history, to inform potential diagnostic, treatment, and referral interventions

    Describing the number of deaths with history of fever, and/or acute febrile illnesses.

    Measured: 18-20 months of recruitment period

  4. Proportion of deaths with acute febrile illness history.

    Describing the proportion of deaths with history of fever, and/or acute febrile illnesses.

    Measured: 18-20 months of recruitment period

  5. Number of causes of death reported from VA and other available sources (local treatment records, diagnoses from other SEACTN components)

    The investigators will identify number of causes of deaths reported from VA and confirmed them against other accessible local treatment records at rural health centers or if possible, nearby hospital or findings from collected biological samples from SEACTN rural febrile illness project.

    Measured: 18-20 months of recruitment period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2020
  2. Study start1 Sep 2021
  3. Primary completion30 Apr 2024
  4. Study completion30 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
3,413 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04595656
Sponsor's protocol ID
HCR20007
Acronym
SEACTN-VA
Status last verified
Jan 2026
First submitted
12 Oct 2020
Last updated
18 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cause of Mortality and Cause of Neonatal Death, run by University of Oxford at 5 sites in 5 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in Bangladesh, Burma, Cambodia, Laos, Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

~2,000 deaths classified according to ICD-10 classification (time frame: 18-20 months recruitment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in